Cleared Traditional

K901615 - PULMOCATH INTRABRONCHIAL CATHETER

K901615 is an FDA 510(k) clearance for PULMOCATH INTRABRONCHIAL CATHETER, manufactured by Omnitron Intl., Inc.. The device is a Class 2 Radiology device with product code JAQ cleared through the Traditional 510(k) pathway after a 966-day FDA review.

K901615 · Omnitron Intl., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1992
Decision
966d
Days
Class 2
Risk

K901615 is an FDA 510(k) clearance for the PULMOCATH INTRABRONCHIAL CATHETER. Classified as System, Applicator, Radionuclide, Remote-controlled (product code JAQ), Class II - Special Controls.

Submitted by Omnitron Intl., Inc. (Lajke Charles, US). The FDA issued a Cleared decision on November 27, 1992 after a review of 966 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5700 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Omnitron Intl., Inc. devices

FDA 510(k) Submission Details - K901615

510(k) Number K901615 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1990
Decision Date November 27, 1992
Days to Decision 966 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
859d slower than avg
Panel avg: 107d · This submission: 966d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAQ Device Classification - Class 2, Special Controls

Product Code JAQ System, Applicator, Radionuclide, Remote-controlled
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAQ System, Applicator, Radionuclide, Remote-controlled

All 182
Devices cleared under the same product code (JAQ) and FDA review panel - the closest regulatory comparables to K901615.
APPLICATORS FOR VARIAN VARISOURCE REMOTE HIGH SOES RATE AFTERLOADER
K952913 · Varian Assoc., Inc. · Nov 1995
HIGH DOSE RATE AFTERLOADER
K945383 · Varian Assoc., Inc. · Feb 1995
HIGH DOSE RATE REMOTE AFTERLOADING CATHETER
K923738 · Cook, Inc. · Apr 1993
GAMMAMED IRIDIUM-192 SOURCE
K894381 · Mick Radio-Nuclear Instruments, Inc. · Nov 1989
GAMMAMED 12I
K891131 · Mick Radio-Nuclear Instruments, Inc. · Aug 1989
CURIETRON
K840127 · Syncor Intl. Corp. · Mar 1984